Skip to content

Pediatric Migraine

Published on:
February 27, 2022
Sign-up Expiration:
"By the time they turn 17, as many as 8% of boys and 23% of girls have experienced a migraine."
This is a research study, or clinical trial, to test a medication approved by the FDA for the treatment of acute migraine and prevention of episodic migraine in adults. The purpose of this study is to learn how well the study drug works and how safe the study drug is to treat migraine in children and teens compared to placebo. The investigational drug, plus all study-related assessments, will be provided at no cost to you.​
The investigational drug being evaluated is called rimegepant.  It has already been approved by the FDA and is currently being prescribed by doctors for the treatment of migraine in adults.

Participants May Receive: 

- Study related evaluations of your migraine related symptoms and overall health
- Compensation for participation may be provided.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials